Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CERP: Comparison of 4 Opioids for Cancer Pain
NCT01809106Phase 4Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Apr 2011
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of oxycodone, buprenorphine, fentanyl in cancer pain, sponsored by Mario Negri Institute for Pharmacological Research. Started Apr 2011; status: completed.
02
Drugs
oxycodonebuprenorphinefentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01809106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01809106.